302
Views
24
CrossRef citations to date
0
Altmetric
Original Article

Prognosis of Malaria Associated Severe Acute Renal Failure in Children

Pages 63-66 | Published online: 07 Jul 2009
 

Abstract

Between January and December 1996, we observed 64 children (mean age 8.3 years range 4.2 to 11.2 years) who required dialysis for severe acute renal failure secondary to Falciparum Malaria. All received anti malarial therapy and other supportive therapy as well as peritoneal dialysis. Out of these 28 died (43.8%).

The children who died (Group I) compared to those who survived (Group II) differed significantly in age (mean ± SD) (7.2 ± 1.3 years vs. 9.2 ± 2.1 years P < 0.05), plasma creatinine at presentation (645 ± 104 μmol/L vs. 438 ± 87 μmol/L P < 0.05), plasma bilirubin (2.1 ± 0.3mg/dL vs. 1.2 ± 0.2mg/dL P > 0.02) systolic BP (50 ± 11 mmHg vs. 90 ± I2mmHgP0 < 0.01), diastolic BP (20 ± 4mmHg vs. 60 ± 9mmHg P <. 01). Hb level 5.3 ± 0.4g/dL vs. 8 ± 1.3gM/dL P <. 02), time from diagnosis to referral (5.3 ±1.3 days vs. 8.9 ± 2.1 days P <.05) and urine output (200 ±49 mL/24 h vs. 600mL ± 131 mL P <. 01). There was no significant difference in gender, alanine transaminase (ALT) level, degree of fever, plasma Na or plasma K.

Diarrhea was present in 29% of the children who died and in only 11% of those who survived (P > 0.05) and splenomegaly was found in 3% and 18% respectively (PO >. 05).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.